Company · CIK 0001579428 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Axsome Therapeutics, Inc. · AXSM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 SForm 4 → | Sep 3, 7:09 pm EDT | Mark L. JacobsonChief Operating Officer | 10,000 | $208.65 | $2,086,500 | 0 | −100% | 10b5-1 |
| Sep 3, 2026 MForm 4 → | Sep 3, 7:09 pm EDT | Mark L. JacobsonChief Operating Officer | 10,000 | $12.95 | $129,500 | 10,000 | — | 10b5-1 |
| Aug 5, 2026 SForm 4 → | Aug 7, 7:00 pm EDT | Herriot TabuteauChief Executive Officer, Director, 10% Owner | 49,664 | $212.19 | $10,538,305 | 7,229 | −87.3% | 10b5-1 |
| Aug 5, 2026 MForm 4 → | Aug 7, 7:00 pm EDT | Herriot TabuteauChief Executive Officer, Director, 10% Owner | 49,664 | $4.95 | $245,837 | 11,889 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 1, 7:30 pm EDT | Herriot TabuteauChief Executive Officer, Director, 10% Owner | 49,666 | $240.25 | $11,932,257 | 7,229 | −87.3% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 1, 7:30 pm EDT | Herriot TabuteauChief Executive Officer, Director, 10% Owner | 49,666 | $4.95 | $245,847 | 56,895 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 MForm 4 → | Sep 3, 7:09 pm EDT | Mark L. JacobsonChief Operating Officer | 10,000 | — | — | 104,954 | — | 10b5-1 |
| Aug 5, 2026 MForm 4 → | Aug 7, 7:00 pm EDT | Herriot TabuteauChief Executive Officer, Director, 10% Owner | 49,664 | — | — | 0 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 1, 7:30 pm EDT | Herriot TabuteauChief Executive Officer, Director, 10% Owner | 49,666 | — | — | 49,664 | — | 10b5-1 |